US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CANSINO BIOLOGICS INC

6.60

+0.621610.40%

Volume:115.00

Turnover:769.80

Market Cap:1.63B

PE:-52.98

High:6.60

Open:6.60

Low:6.60

Close:5.98

52wk High:6.60

52wk Low:2.52

Shares:247.04M

Float Shares:127.43M

Volume Ratio:6.78

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1246

EPS(LYR):-0.2096

ROE:-3.35%

ROA:-1.96%

PB:2.36

PE(LYR):-31.49

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CANSINO BIOLOGICS INC

Exchange:

PINK LIMITED

Establishment Date:

2009

Employees:

1115

Office Location:

401-420, Biomedical Park,4th Floor,185 South Avenue,TEDA West District,Tianjin,China

Website:

- -

Zip Code:

300457

Phone:

86 022 5821 3600

Fax:

86 022 5821 3677

Introduction:

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CS-2023 to treat meningitis; CS-2028 for treating multivalent conjugate vaccine; CS-2032 for hingles; CS-2036 to treat polio; CS-2047 for treating tetanus; and CS-2201 DTcP for combination vaccine. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CASBF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CASBF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CASBF\",,,,,undefined,":{"symbol":"CASBF","market":"US","secType":"STK","nameCN":"CANSINO BIOLOGICS INC","latestPrice":6.6,"timestamp":1758119137486,"preClose":5.9784,"halted":0,"volume":115,"delay":15,"floatShares":127431195,"shares":247043801,"eps":-0.124576,"marketStatus":"Trading","change":0.6216,"latestTime":"09-17 10:25:37 EDT Delay","open":6.6,"high":6.6,"low":6.6,"amount":769.8,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.124576,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1758139200000},"marketStatusCode":2,"adr":0,"exchange":"PINK LIMITED","adjPreClose":5.9784,"volumeRatio":6.777801},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CASBF\",,,,,undefined,":{"symbol":"CASBF","floatShares":127431195,"roa":"-1.96%","roe":"-3.35%","lyrEps":-0.209615,"volumeRatio":6.777801,"shares":247043801,"dividePrice":0,"high":6.6,"amplitude":0,"preClose":5.9784,"low":6.6,"week52Low":2.515,"pbRate":"2.36","psRate":"12.50","week52High":6.6,"institutionHeld":0,"latestPrice":6.6,"eps":-0.124576,"divideRate":0,"volume":115,"delay":15,"ttmEps":-0.124576,"open":6.6,"prevYearClose":4.001,"prevWeekClose":5.9784,"prevMonthClose":6.26,"prevQuarterClose":3.2,"fiveDayClose":5.9784,"twentyDayClose":6.26,"sixtyDayClose":3.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CASBF\",params:#limit:5,,,undefined,":[{"date":"2024-04-30","symbol":"CASBF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1714464000000,"name":null,"time":"Pre-Market","dateTimestamp":1714449600000,"actualEps":null},{"market":"US","date":"2022-10-28","symbol":"CASBF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1666929600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-08-26","symbol":"CASBF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1661486400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-07-13","symbol":"CASBF","amount":0.8,"defaultRemindTime":1657719000000,"name":"CANSINO BIOLOGICS INC","recordDate":"2022-08-19","payableDate":"2022-07-14","currency":"CNY","type":"dividend","dateTimestamp":1657684800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CASBF\",market:\"US\",,,undefined,":[{"executeDate":"2022-07-13","recordDate":"2022-07-14","paymentDate":"2022-08-19","value":0.8,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CASBF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1744171200000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":108945349,"yearFounded":2009,"employeeNum":1115,"address":"401-420, Biomedical Park,4th Floor,185 South Avenue,TEDA West District,Tianjin,China","zipCode":"300457","officePhone":"86 022 5821 3600","officeFax":"86 022 5821 3677"},"stockCompanyDetail":{"description":"CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CS-2023 to treat meningitis; CS-2028 for treating multivalent conjugate vaccine; CS-2032 for hingles; CS-2036 to treat polio; CS-2047 for treating tetanus; and CS-2201 DTcP for combination vaccine. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.","exchange":"PINK LIMITED","name":"CANSINO BIOLOGICS INC","nameEN":"CANSINO BIOLOGICS INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CASBF\",market:\"US\",,,undefined,":null}}